Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
6
×
boston top stories
life sciences
national blog main
fda
clinical trials
national top stories
san francisco blog main
san francisco top stories
boston
investing
ipo
san diego blog main
san diego top stories
seattle blog main
seattle top stories
boulder/denver blog main
boulder/denver top stories
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
medical device
medical devices
medicare
messenger rna
national
new york blog main
new york top stories
nonalcoholic steatohepatitis
novartis
raleigh-durham blog main
raleigh-durham top stories
texas blog main
texas top stories
venture capital
wisconsin blog main
wisconsin top stories
What
million
6
×
therapeutics
6
×
ipo
raised
new
cancer
company
developing
drug
public
sciences
startup
treat
adding
allogene
analytics
bets
bio
biofourmis
biotech
biotechs
boost
brings
club
companies
continued
crispr
crop
data
debut
devices
digital
disorders
diversity
dyne
dyne’s
employs
exceeded
expensive
far
Language
unset
Current search:
million
×
" boston blog main "
×
therapeutics
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
5 years ago
To Boost Cancer Pipeline, Gilead Bets at Least $50M on Startup Tango
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M